Geneva, May 4 -- International Clinical Trials Registry received information related to the study (CTRI/2026/04/109106) titled 'Safety and Efficacy of Puresta Hydrate Serum for Improving Skin Hydration' on April 22.
Study Type: PMS
Study Design:
Single Arm Study Method of generating randomization sequence:Not Applicable Method of allocation concealment:Not Applicable Blinding and masking:Open Label
Primary Sponsor: Puresta Lifestyle Private Limited
Intervention:
Intervention1: Test Product: Hydrate Serum: Test Product: Hydrate Serum
Dose: 5-6 drops applied on face and neck area twice a day
Route of Administration: Topical
Control Intervention1: Not Applicable: Not Applicable
Recruitment Status: Not Recruiting
Phase: Post M...